What is the treatment for hyperkalemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Severe Hyperkalemia (K+ 6.5 mEq/L)

A potassium of 6.5 mEq/L is a medical emergency requiring immediate hospital admission and urgent treatment to prevent life-threatening cardiac arrhythmias, regardless of symptoms. 1, 2, 3

Immediate Assessment (Within Minutes)

  • Obtain an ECG immediately to assess for cardiac manifestations including peaked T waves, flattened P waves, prolonged PR interval, or widened QRS complex 1, 2
  • Rule out pseudohyperkalemia by verifying proper blood sampling technique (no fist clenching, no hemolysis, prompt processing) 1, 4
  • Any ECG changes mandate emergency treatment regardless of the exact potassium level 1, 2

Emergency Treatment Algorithm

Step 1: Cardiac Membrane Stabilization (Start Immediately if ECG Changes Present)

Administer intravenous calcium first to protect against arrhythmias within 1-3 minutes: 5, 1, 4

  • Calcium gluconate 10%: 15-30 mL IV over 2-5 minutes (preferred for peripheral access) 1, 4
  • Alternative: Calcium chloride 10%: 5-10 mL IV over 2-5 minutes (central line preferred) 1, 4
  • Critical caveat: Calcium does NOT lower potassium—it only stabilizes the cardiac membrane temporarily (30-60 minutes) 5, 1, 4
  • May repeat dose if no ECG improvement within 5-10 minutes 4
  • Continuous cardiac monitoring is mandatory during and after administration 4

Step 2: Shift Potassium Intracellularly (Administer Simultaneously)

Give all three agents together for maximum effect: 5, 1, 4

  • Insulin 10 units regular IV + 25g dextrose (50 mL of D50W) - onset 15-30 minutes, lasts 4-6 hours 5, 1, 4

    • Must give glucose with insulin to prevent hypoglycemia 5, 4
    • Monitor glucose every 1-2 hours for 4-6 hours after administration 4
    • Can repeat every 4-6 hours if hyperkalemia persists 4
  • Nebulized albuterol 10-20 mg in 4 mL - onset 30 minutes, lasts 2-4 hours 5, 1, 4

    • Use as adjunctive therapy with insulin 5, 4
  • Sodium bicarbonate 50 mEq IV over 5 minutes ONLY if metabolic acidosis present (pH <7.35, bicarbonate <22 mEq/L) 5, 1, 4

    • Do NOT use if no acidosis—it is ineffective and potentially harmful 5, 4
    • Onset 30-60 minutes 5, 4

Step 3: Remove Potassium from Body (Initiate Within 1 Hour)

Choose based on renal function and clinical context: 5, 1, 4

  • Loop diuretics (furosemide 40-80 mg IV) if adequate kidney function (eGFR >30 mL/min) and patient is not oliguric 5, 1, 4

  • Hemodialysis is the most effective and reliable method for severe hyperkalemia, especially if: 5, 1, 4, 3

    • Oliguria or end-stage renal disease present 5, 4
    • Refractory to medical management 5, 3
    • Ongoing tissue breakdown or potassium release 5
  • Newer potassium binders (preferred over sodium polystyrene sulfonate): 1, 4, 6

    • Sodium zirconium cyclosilicate (SZC/Lokelma) 10g three times daily for 48 hours - onset within 1 hour, then 5-15g daily for maintenance 4, 6
    • Patiromer (Veltassa) 8.4g once daily - onset ~7 hours, less useful acutely 4, 6

Medication Management During Acute Episode

At K+ 6.5 mEq/L, temporarily discontinue or reduce RAAS inhibitors (ACE inhibitors, ARBs, mineralocorticoid antagonists) 1, 2, 4

  • Also review and hold: NSAIDs, potassium-sparing diuretics, trimethoprim, heparin, beta-blockers, potassium supplements, salt substitutes 5, 4

Monitoring Protocol

  • Recheck potassium every 2-4 hours after initial treatment until stable below 5.5 mEq/L 4
  • Continuous cardiac monitoring until potassium <6.0 mEq/L 1, 2
  • Monitor glucose hourly for 4-6 hours after insulin administration 4

After Acute Resolution: Preventing Recurrence

Once potassium <5.5 mEq/L, initiate potassium binder and restart RAAS inhibitors at lower dose (if indicated for heart failure or proteinuric kidney disease): 5, 1, 4

  • Start SZC 5-10g daily or patiromer 8.4g daily 4, 6
  • Do NOT permanently discontinue RAAS inhibitors—they provide mortality benefit in cardiovascular and renal disease 1, 2, 4
  • Recheck potassium within 1 week of restarting RAAS inhibitors 5, 4

Critical Pitfalls to Avoid

  • Never delay treatment while waiting for repeat lab confirmation if ECG changes are present 1, 2
  • Never use sodium bicarbonate without metabolic acidosis—it is ineffective and wastes time 5, 4
  • Never give insulin without glucose—hypoglycemia can be life-threatening 5, 4
  • Remember that calcium, insulin, and beta-agonists are temporizing measures only—they do NOT remove potassium from the body 5, 4
  • Do not rely solely on ECG findings—they are variable and less sensitive than lab values 4
  • Avoid sodium polystyrene sulfonate (Kayexalate)—it has delayed onset and risk of bowel necrosis 4, 6

References

Guideline

Evaluation and Treatment of Hyperkalemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hyperkalemia Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment and pathogenesis of acute hyperkalemia.

Journal of community hospital internal medicine perspectives, 2011

Guideline

Hyperkalemia Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Potassium Disorders: Hypokalemia and Hyperkalemia.

American family physician, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.